Verona Pharma plc Announces Pricing of Upsized Underwri

LONDON and RALEIGH, N.C., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage...

Related Keywords

New York , United States , Georgia , United Kingdom , London , City Of , Atlanta , Wedbush Pacgrow , Kimberly Minarovich Michael Barron , Verona Pharma , International Media , Financial Services , Nasdaq , Truist Securities Inc , Exchange Commission , While The Company , Strategic Communications , Prospectus Department , Equity Syndicate Prospectus Department , European Union Withdrawal , Piper Sandler Co , Hc Wainwright Co , Depositary Shares , Piper Sandler , Truist Securities , Annual Report , European Union , Kingdom Prospectus , European Economic Area , United Kingdom Prospectus Regulation , Markets Act , Financial Promotion , Qualified Investors , Relevant States , Relevant Persons , Relevant State , Kingdom Tel , Investor Relations , European Investor Enquiries , Stella Lempidaki , Nasdaq Vrna , Verona Pharma Plc ,